PLoS ONE · 2021 · 20 citations · 20 references
PharmacyInternal MedicineChronic Illness Self-managementOutcomes ResearchSelf-management SupportChronic Obstructive Pulmonary DiseasePatient-centered Outcomes ResearchPatient-reported OutcomesSelf-managementPatient Outcomes MeasurementPerson-centred Care PlanningPotential OutcomesRelative Effectiveness EstimationSelf-management Interventions
BACKGROUND: A large body of evidence suggests that self-management interventions (SMIs) may improve outcomes in chronic obstructive pulmonary disease (COPD). However, accurate comparisons of the relative effectiveness of SMIs are challenging, partly due to heterogeneity of outcomes across trials and uncertainty about the importance of these outcomes for patients. We aimed to develop a core set of patient-relevant outcomes (COS) for SMIs trials to enhance comparability of interventions and ensure person-centred care. METHODS: We undertook an innovative approach consisting of four interlinked stages: i) Development of an initial catalogue of outcomes from previous EU-funded projects and/or published studies, ii) Scoping review of reviews on patients and caregivers' perspectives to identify outcomes of interest, iii) Two-round Delphi online survey with patients and patient representatives to rate the importance of outcomes, and iv) Face-to-face consensus workshop with patients, patient representatives, health professionals and researchers to develop the COS. RESULTS: From an initial list of 79 potential outcomes, 16 were included in the COS plus one supplementary outcome relevant to all participants. These were related to patient and caregiver knowledge/competence, self-efficacy, patient activation, self-monitoring, adherence, smoking cessation, COPD symptoms, physical activity, sleep quality, caregiver quality of life, activities of daily living, coping with the disease, participation and decision-making, emergency room visits/admissions and cost effectiveness. CONCLUSION: The development of the COPD COS for the evaluation of SMIs will increase consistency in the measurement and reporting of outcomes across trials. It will also contribute to more personalized health care and more informed health decisions in clinical practice as patients' preferences regarding COPD outcomes are more systematically included.
20
Rafael Lozano, Mohsen Naghavi, Kyle J Foreman et al. · The Lancet · 2012 · 14.3K citations · Full text
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Colin Mathers, Dejan Lončar · PLoS Medicine · 2006 · 11.5K citations · Full text
Theo Vos, Abraham D Flaxman, Mohsen Naghavi et al. · The Lancet · 2012 · 8.4K citations · Full text
Developing core outcome sets for clinical trials: issues to consider
Paula Williamson, Douglas G. Altman, Jane Blazeby et al. · Trials · 2012 · 1.7K citations · Full text
Core Outcome Set-STAndards for Development: The COS-STAD recommendations
Jamie J Kirkham, Douglas G. Altman, Jane Blazeby et al. · PLoS Medicine · 2017 · 795 citations · Full text